Recalls / Brands / Ondansetron
Ondansetron
5 FDA drug recalls involving brand “Ondansetron”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-12-30 | Class II | Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), R | Glenmark Pharmaceuticals Inc., USA |
| 2019-05-22 | Class III | Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047 | Fresenius Kabi USA, LLC |
| 2013-09-24 | Class II | Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake F | Hospira Inc. |
| 2013-05-20 | Class II | Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-0 | Hospira, Inc. |
| 2012-09-27 | Class II | ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pha | Fresenius Kabi USA, LLC |